|
|||||
|
|
Sustained Carbohydrate Antigen 19-9 Response to Neoadjuvant Chemotherapy in Borderline Resectable Pancreatic Cancer Predicts Progression and Survival |
|
| Authors: | J. Bart Rose Alicia M. Edwards Flavio G. Rocha Carolyn Clark Adnan A. Alseidi Thomas R. Biehl Bruce S. Lin Vincent J. Picozzi W. Scott Helton |
| Affiliation: | 1. Division of Surgical Oncology, University of Alabama, Birmingham, Alabama, USA;2. Section of General, Thoracic and Vascular Surgery, Seattle, Washington, USA;3. Section of Hematology and Oncology, Virginia Mason Medical Center, Seattle, Washington, USA |
| Abstract: | |
| Keywords: | Pancreas cancer Carbohydrate antigen 19-9 Neoadjuvant Biomarker Borderline resectable |